Wave Life Sciences, Inc. - 8-K Filing

Wave Life Sciences stockholders approve amendment to 2021 Equity Incentive Plan increasing authorized shares by 11 million and re-elect nine directors. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $WVE

Read the full article at SEC EDGAR

More Regulatory news